Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-21

FDA Approved: DAPTOMYCIN — Original Application (Hospira, Inc.)

View source ↗

Summary

FDA approved daptomycin (Hospira) under the original application NDA210282, establishing its use for complicated skin and skin structure infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daptomycin (daptomycin)

Snippet

ORIG AP for DAPTOMYCIN (DAPTOMYCIN)